Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,293
Closed -$3.04M 1018
2021
Q3
$3.04M Buy
+14,293
New +$3.29M 0.12% 154
2020
Q4
Sell
-940
Closed -$239K 519
2020
Q3
$239K Buy
+940
New +$233K 0.02% 371
2020
Q2
Sell
-2,995
Closed -$607K 478
2020
Q1
$607K Buy
+2,995
New +$654K 0.05% 188
2018
Q1
Sell
-3,388
Closed -$589K 378
2017
Q4
$589K Buy
+3,388
New +$600K 0.04% 210
2017
Q3
Sell
-3,450
Closed -$594K 329
2017
Q2
$594K Buy
+3,450
New +$561K 0.07% 154

Other funds holding AMGN

Old Mission Capital's AMGN Position: Q4 2021 in Review

Old Mission Capital sold out of Amgen (AMGN) in Q4 2021, closing a stake of 14,293 shares — an estimated $3.04M sold.

Old Mission Capital first reported a position in AMGN in Q2 2017 and held it in 5 quarters. The position peaked at $3.04M in Q3 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Old Mission Capital reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Old Mission Capital sold 14,293 Amgen shares in Q4 2021, an estimated $3.04M.
  • Old Mission Capital first reported a position in Amgen in Q2 2017 and held it in 5 quarters.
  • Old Mission Capital's Amgen position peaked at $3.04M in Q3 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Old Mission Capital's 13F filing for Q4 2021, filed 10 Feb 2022.